Literature DB >> 31465067

Kinetic stability-driven cytotoxicity of small-molecule prodrug nanoassemblies.

Yang Li1, Yuwen Chen, Yulan Huang, Wenbi Wu, Yu Liu, Jing Zhang, Meijuan Huang, Maling Gou.   

Abstract

Nanoassemblies (NAs) of small-molecule lipophilic prodrugs have been widely investigated for efficient drug delivery in cancer therapy, but their kinetic stability has not attracted sufficient attention in the past studies. Herein, we reported that kinetic stability has a great influence on the drug release from the NAs of lipophilic prodrugs in physiologically relevant media. Based on the co-assembled FRET nanosystems of two lipophilic fluorescent prodrugs, we demonstrated that NAs constructed by lipophilic prodrugs containing shorter alkyl chains or those with higher unsaturated degrees displayed poorer kinetic stability, which further resulted in remarkably faster drug release in mouse plasma and various tissue homogenates. More importantly, these kinetically unstable NAs also induced rapid intracellular drug release, resulting in much more potent cytotoxicity. These findings highlight the crucial role of kinetic stability in determining the drug release from the NAs of lipophilic prodrugs, which would effectively guide their rational designs for cancer therapy.

Entities:  

Year:  2019        PMID: 31465067     DOI: 10.1039/c9tb01270b

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy.

Authors:  Fu Li; Zhao Huang; Huitong Chen; Lu Yan; Jin Li; Yue Su; Qian Zhang; Zhengye Huang; Yaxin Zheng
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

2.  Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles.

Authors:  Mei-Qi Xu; Ting Zhong; Xin Yao; Zhuo-Yue Li; Hui Li; Jing-Ru Wang; Zhen-Han Feng; Xuan Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.